Altered Glycosylation of Proteins in Cancer: What Is the Potential for New Anti-Tumour Strategies

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 1, 2008-01 ,pp. : 2-21

Bentham Science Publishers

Access to resources Recommend Favorite

Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy

By Silverman Daniel   Dy Christine   Castellon Steven   Lai Jasmine   Pio Betty   Abraham Laura   Waddell Kari   Petersen Laura   Phelps Michael   Ganz Patricia  

Breast Cancer Research and Treatment, Vol. 103, Iss. 3, 2007-07 ,pp. : 303-311

Springer Publishing Company

Access to resources Recommend Favorite

Modulation by lonidamine on the combined activity of cisplatin and epidoxorubicin in human breast cancer cells

By Silvestrini R.   Gornati D.   Zaffaroni N.   Bearzatto A.   de Marco C.  

Breast Cancer Research and Treatment, Vol. 42, Iss. 2, 1997-01 ,pp. : 103-112

Springer Publishing Company

Access to resources Recommend Favorite

Anticancer Activity of Bisphosphonates in Breast Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-01 ,pp. : 114-122

Bentham Science Publishers

Access to resources Recommend Favorite

Altered Rho GTPase Signaling Pathways in Breast Cancer Cells

By Burbelo Peter   Wellstein Anton   Pestell Richard G.  

Breast Cancer Research and Treatment, Vol. 84, Iss. 1, 2004-03 ,pp. : 43-48

Springer Publishing Company

Access to resources Recommend Favorite